Verrica Pharmaceuticals's top three insider shareholders as of April 17, 2026 are Paul B Manning (Director, 7.31Mn shares), Advisors Llc Perceptive (TenPercentOwner, 7.10Mn shares), Advisors Llc Perceptive (TenPercentOwner, 7.10Mn shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Paul B Manning | - | 3,958,189 | 3,348,372 | 25 Nov, 2025 |
| Advisors Llc Perceptive | - | 0 | 7,099,182 | 29 Dec, 2023 |
| Advisors Llc Perceptive | - | 0 | 7,099,182 | 29 Dec, 2023 |
| John A Iii Stalfort | - | 1,873,800 | 0 | 26 Nov, 2024 |
| Paul B Manning | - | 0 | 891,870 | 23 Sep, 2024 |
| Ted White | President And Ceo | 215,967 | 0 | 28 Aug, 2024 |
| Jayson Rieger | Ceo And President | 182,593 | 0 | 25 Nov, 2025 |
| Christopher G. Hayes | Chief Legal Officer | 176,458 | 0 | 18 Mar, 2025 |
| Gary Goldenberg | Chief Medical Officer | 94,261 | 0 | 28 Aug, 2024 |
| Joe Bonaccorso | Chief Commercial Officer | 73,114 | 0 | 28 Aug, 2024 |
| Terry Kohler | Chief Financial Officer | 44,697 | 0 | 28 Aug, 2024 |
| David Zawitz | Chief Operating Officer | 21,000 | 0 | 25 Nov, 2025 |
| John J. Kirby | Interim Cfo | 18,962 | 0 | 30 Dec, 2025 |
| Noah L. Rosenberg | Cmo | 2,357 | 0 | 25 Nov, 2025 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 23 Dec, 2025 | John J. Kirby | Common Stock | A | 10,000 | $0.00 | 18,962 | D | A |
| 25 Nov, 2025 | Jayson Rieger | Common Stock | A | 94,311 | $4.24 | 182,593 | D | P |
| 25 Nov, 2025 | John J. Kirby | Common Stock | A | 3,536 | $4.24 | 8,962 | D | P |
| 25 Nov, 2025 | David Zawitz | Common Stock | A | 10,000 | $4.24 | 21,000 | D | P |
| 25 Nov, 2025 | Paul B Manning | Common Stock | A | 1,375,380 | $4.24 | 3,958,189 | D | P |
| 25 Nov, 2025 | Noah L. Rosenberg | Common Stock | A | 2,357 | $4.24 | 2,357 | D | P |
| 25 Nov, 2025 | Noah L. Rosenberg | Series C Warrant (right to buy) | A | 589 | - | 589 | D | P |
| 25 Nov, 2025 | John J. Kirby | Series C Warrant (right to buy) | A | 884 | - | 884 | D | P |
| 25 Nov, 2025 | Paul B Manning | Common Stock | A | 2,750,762 | $4.24 | 3,348,372 | I | P |
| 25 Nov, 2025 | David Zawitz | Series C Warrant (right to buy) | A | 2,500 | - | 2,500 | D | P |
| 25 Nov, 2025 | Jayson Rieger | Series C Warrant (right to buy) | A | 23,577 | - | 23,577 | D | P |
| 25 Nov, 2025 | Paul B Manning | Series C Warrant (right to buy) | A | 343,845 | - | 343,845 | D | P |
| 25 Nov, 2025 | Paul B Manning | Series C Warrant (right to buy) | A | 687,690 | - | 687,690 | I | P |
| 05 Jun, 2025 | Gavin Corcoran | Stock Option (right to buy) | A | 20,000 | $0.00 | 20,000 | D | A |
| 05 Jun, 2025 | Lawrence Eichenfield | Stock Option (right to buy) | A | 20,000 | $0.00 | 20,000 | D | A |
| 05 Jun, 2025 | Mark A Sr Prygocki | Stock Option (right to buy) | A | 20,000 | $0.00 | 20,000 | D | A |
| 05 Jun, 2025 | Diem Nguyen | Stock Option (right to buy) | A | 20,000 | $0.00 | 20,000 | D | A |
| 31 Mar, 2025 | Gavin Corcoran | Stock Option (right to buy) | A | 17,502 | $0.00 | 17,502 | D | A |
| 24 Mar, 2025 | Noah L. Rosenberg | Employee Stock Option (right to buy) | A | 325,000 | $0.00 | 325,000 | D | A |
| 14 Mar, 2025 | Jayson Rieger | Employee Stock Option (right to buy) | A | 850,000 | $0.00 | 850,000 | D | A |